Skip to main content
NIH funding notice RFA-AG-23-007

Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional)

Closed on July 11, 2022.

Posted
February 23, 2022
Close date
July 11, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,279,978 in first-year total cost, median $1,279,978.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-4 (J1)]1

Most frequent institutions

  1. NORTHWESTERN UNIVERSITY AT CHICAGO1
Competing awards under RFA-AG-23-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023ARMCADA - Advancing Reliable Measurement in Cognitive Aging and Decision-making Ability1U24AG082022-01GERSHON, RICHARDWEINTRAUB, SANDRANORTHWESTERN UNIVERSITY AT CHICAGO, IL$1,279,978ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.